At Fujifilm, we are committed to doing our part, at every opportunity, to deliver value through imaging innovation. ASPIRE Cristalle with Digital Breast Tomosynthesis (DBT) is built smarter because it is built with insight into image quality, operational excellence, and a better patient experience.
The intelligent design of ASPIRE Cristalle’s patented Comfort Paddle provides noticeably less pain and anxiety for the patient. With its unique flexible, slotted 4-way tilting paddle design, it provides more even compression, that combined with the Intelligent Automatic Exposure Control (iAEC) image processing, make it possible to provide more optimized images at low dose for every breast type, including implants.
Our advanced technology simplifies and speeds workflow so technologists can spend more time focused on patient interactions.
The unique Hexagonal Close Pattern (HCP) detector pixel design on ASPIRE Cristalle outperforms traditional pixel arrays to help enable superior diagnostic accuracy for radiologists.
When compared to square pixels, HCP delivers:
It’s critical to think about the bigger picture when introducing DBT to your facility to keep your facility running as efficiently as possible. Our Synapse® Enterprise Imaging portfolio, including Synapse 5 PACS and Synapse VNA, enables secure, easy-to-manage storage and access to the complete patient imaging record throughout the healthcare enterprise, regardless of the technology-generating source, format type, or siloed storage system.
The unique Comfort Paddle allows pressure to be more evenly and gently distributed across the breast compared to conventional, flexible paddles.
Learn more about the Comfort Paddle and other accessories here.
Contrast-enhanced digital mammography (CEDM) uses a dual-energy technique performed after the IV administration of iodinated contrast agent to identify abnormalities on the basis of angiogenesis, as well as morphologic features and density.
The physiologic information provided by CEDM is similar to that provided by breast MRI, without the added time or expense of conventional breast MRI protocols. The combination of morphologic and physiologic information provided by CEDM has been shown to provide superior sensitivity and specificity in diagnosing breast cancer when compared with digital mammography alone .
For many, the word mammogram is associated with anxiety and fear of a painful exam. Pain associated with mammography screenings results from compression of the breast, which is required to obtain high-quality mammograms at low radiation doses.
Comfort Comp leverages the phenomenon of hysteresis in which soft tissues, such as breast tissue, maintain their position for a period of time before returning to their neutral position. Mammography using Comfort Comp requires that normal breast compression be applied initially to ensure proper breast positioning and to take full advantage of the hysteresis principle. Comfort Comp triggers an automatic reduction in the amount of compression force after normal breast compression is completed and prior to exposure. Once completed, automatic decompression is activated, shortening the time that the breast is under maximum pressure with minimal changes to breast thickness or image quality.
Read the full white paper on Comfort Comp to learn how the feature is designed to augment patient comfort through decreased compression without compromising image quality or workflow.
Radiologists using ASPIRE Cristalle with DBT will realize valuable, enhanced clinical efficacy compared to using full field digital mammography (FFDM) alone.
Optimized x-ray dose and contrast for each breast type. Fujifilm’s proprietary technology makes it possible to lower dose while offering optimized contrast, even in dense breasts and implants.
In an effort to promote women’s health, we are traveling across the 48 contiguous U.S. states in our ‘Aspire to Be Fearless’ mobile mammography coach, which is outfitted with the ASPIRE Cristalle 3D mammography system and a Bellus II mammography workstation.
Our coach hosts educational opportunities for clinicians, raises awareness about the importance of screening, and seeks clinical partners to provide mammograms to underserved populations in key locations.
We are committed to improving women’s health by improving access to breast health education and mammography screening services for every woman who needs it.
ASPIRE Cristalle, Fujifilm’s third-generation full-field digital mammography (FFDM) system, now delivers optimum image quality at a very low patient dose. A new white paper, Technology Advances in Mammography: Dose Reduction and Image Quality, highlights the recent advances in FFDM technology employed in the ASPIRE Cristalle system.
Download the white paper to learn how:
Fujifilm is committed to supporting technologists with continuing education offerings. Select from multiple webinar options to view and acquire CE credits.
This webinar will provide the audience with a unique perspective, that of a Medical Physicist, when evaluating and considering mammography systems from four different vendors. Discussion topics include elements to consider for a reliable mammography system, understanding the technology and system testing differences between each vendor, and the importance of an efficient QC testing process upon installation.
In this Expert Forum, Dr. Matthew Covington shares his understanding of the benefits and limitations of contrast-enhanced mammography, as compared to contrast-enhanced breast MRI, and how this imaging technique can be incorporated into clinical practice.
Dr. Laurie Fajardo will share her understanding of the benefits of synthetic 2D images with digital breast tomosynthesis (DBT) for diagnosing breast cancer along with considerations for implementing Synthetic 2D breast imaging protocols into your practice.
Meet our Women’s Health Team, a dedicated group of professionals fueled by an unwavering passion for improving women’s well-being. At the core of our mission is the commitment to providing cutting-edge mammography equipment to empower healthcare providers with the tools they need to conduct screenings, fostering a collective effort to reduce the risk of breast cancer and promote women’s health.
“As a survivor involved in women’s health for Fujifilm, my passion comes from being confident that our premium products will provide patients like me with a better chance for a positive outcome.”
Stephanie Fogel, Women’s Health Regional Director-Midwest
“I love that we are bringing education and visibility to the market for women’s health technology that drives innovation, a better patience experience and better outcomes.”
David Prater, National Director Women’s Health
“What I love most about being a part of Fujifilm’s Women’s Health team is the knowledge, experience and passion that everyone brings to the table every day. We are committed to providing our customers and their patients, with the best technology available.”
Christine Murray, Sr. Product Marketing Manager
“Mammography has been my way to make a difference in the lives of the people around me. Helping give people more time with the ones they love makes me feel like a super hero.”
Tammy Handley, Senior Project Manager
“The biggest challenge in the early detection of breast cancer is encouraging women to have regular screening mammograms. In addition to exceptional image quality, the ASPIRE Cristalle has specific features to enhance patient comfort and alleviate fears. Being a Clinical Consultant for Fujifilm is so fulfilling as their passion for women’s health matches our own.”
Marie Paroz and Kellen Gill, Clinical Consultants
“I love being a part of a team that brings 100% everyday, all the time. We are laser-focused on providing our customers with the best breast imaging solutions. Because early detection is key to finding cancer – and this requires women getting their annual mammogram. Women should be afraid of getting cancer, not the mammogram.”
Melanie Niedringhaus, Product Manager
“I enjoy solving complex problems in an environment that is challenging and has a tangible impact on the world. Servicing Digital Breast Imaging Systems is both complex and challenging and is a critical aspect of early cancer detection which is vital in the fight against breast cancer – and I’m glad I have the opportunity to be a small part of that fight.”
Vince McInnis, Product Support Specialist
“I am proud of the relationships that Fujifilm has built with facilities that are working hard to remove barriers that prevent women from accessing mammography services.”
Trish Gifford, Sr. Clinical Consultant
Fujifilm works with the following partners to provide additional features for ASPIRE Cristalle, ASPIRE HD Plus and ASPIRE HD.
iCAD is an industry-leading provider of Computer-Aided Detection (CAD) technologies, advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. iCAD offers a comprehensive range of high-performance, upgradeable CAD solutions for mammography and advanced image analysis and workflow solutions for Magnetic Resonance Imaging, for breast and prostate cancers and Computed Tomography for colorectal cancer. iCAD’s Xoft System, offers radiation treatment for early-stage breast cancer that can be administered in the form of Intraoperative Radiation Therapy or accelerated partial breast irradiation. The Xoft System is also cleared for the treatment of non-melanoma skin cancer and gynecological cancers.
Volpara Solutions builds innovative, quantitative breast imaging solutions tools built on the Volpara algorithm which enables the generation of volumetric measurements of density, patient specific dose, breast compression and other factors that provide actionable intelligence designed to help maintain accuracy and consistent quality in breast screening.
To date, more than 2 million women have had their volumetric breast density analyzed using VolparaDensity. Cleared by the FDA, HealthCanada, the TGA and CE-marked, VolparaDensity is used by radiologists to objectively assess density from both digital mammography and tomosynthesis images and help evaluate who might benefit from additional screening. Highly correlated to breast MR assessments, VolparaDensity is a reliable tool which automatically generates an objective, automatic measurement of volumetric breast density and a FDA cleared BI-RADS breast density category.
VolparaAnalytics assists in quality assurance by monitoring critical elements of the breast imaging process and generating key metrics to help understand the performance of technologists, readers, and mammography and tomosynthesis machines.
VolparaDose improves the accuracy of mammography dose reporting by using a standard mean glandular dose (MGD) algorithm along with patient-specific volumetric breast density to give a better estimate of the dose absorbed by the specific breast.
